Member Info for paulus47

Half decent buy of 150k earlier may signal something?

Only because it’s not worth selling at this level if you’re unlucky enough to be a shareholder already. Go figure.

Could be worse! Angela Rayner might have joined the BoD.

Is something happening ?

Only 43m shares . Sustained buying tomorrow and this will rise quickly.

The bid moved up immediately afterwards, albeit only a touch.

I suspect the scheme will be sold on once planning for change of use is given. Therefore no need for building finance. That’s what I would do.

Interesting flurry at the close. Not a lot of money but good to see some interest. Maybe some news next week?

And another dummy sell just went through, 120 shares. Depends on one’s interpretation of the meaning I guess.

I think some optimism is welcome here providing it is factual. My thought is stay focussed, buy at these levels and hold.

Laura, I think ther is a shortage of stock at the moment and the only sells so far are the small quantities which don’t add up to much and only serve to mask a much needed uplift on the bid. Looking at these small trades over a recent period they seem to be timed to follow a few buys but in the longer run will run out of steam and can’t be based on a financial decision. All in my opinion but I think this wants to go higher from these low levels. I added this morning early.

Morning all. The usual crop of small trades today but keep a focus on the larger buys which in my opinion point the way this will play out. Someone thinks the sp is way undervalued and is snapping up shares on a regular basis and based on the science they are correct in their judgement and are buying in cheaply at these low levels. That’s how it looks to me..

This is what Sareum will be aligned to, huge value compared with current Mcap and only some of us can see it. Others sell their 200 and 300 shares for their own reason but as John McInroe famously said “ you cannot be serious”.

Oh look, another sale of 69 shares @ 16p to keep up the negativity. We have someone playing their joker or blind man’ s bluff with the ever cooperative mms.

Spot on PCS. Meanwhile the early morning tiny sell goes through at 16p in order to raise enough cash for a breakfast, and keep the price down. As someone told me recently “ let them play, they have no idea! “

I mentioned the SKIL platform recently and it is interesting this came out in the RNS today so back on the radar with great value potential I think. I note Merck’s purchase of SpringWorks Theraputics for £3.9B announced today which reaffirms the spending power in our market and, I would think Sareum’s value continues to rise and the market will wake up soon to our worth. Anyone selling at these low levels is entirely misreading what’ s going to happen here soon enough in my opinion. So, like others I am buying from the weak and awaiting good news.

Think about it. 3 compounds progressing, funded and institutional buying. Chairman topping up too at this level. Seems cheap to me so will be buying and holding for the commercialisation of the 3 compounds. Seems crazy to sell any at this price with all this potential in the offing. GLA all there lths

Hi to all LTHs and recent holders. I was thinking about how SAR are regarded in the market by the bigger Pharmas who no doubt have a pretty good idea about our 3 current compounds and potential value and how de risked we may be now as things progress. What I haven’t seen for sometime is any reference to the SKIL platform which was certainly regarded by the Directors as a very valuable asset when mentioned at several AGMs. Does anyone have an update? Given the flurry of interest today which may well reflect the added valueb introduced by SR737 and recent large buys in the market, we may have something else under the radar. I still anticipate the Company will monetise these assets and reward patience. Let’s be positive!

Very positive to see the 650k share buy following other decent recent buys. What is needed now is an upward movement in the share price to reflect this confidence and whilst not linking directly I note the 85% rise in Corcept Theraputics following successful late stage ovarian cancer trial results from it’s Phase3 ROSSELLA trial. We of course have SA737 back plus 1801 and 1802. So it seems more confirmation of how undervalued we are.

Not too difficult to see bailiff. Buys have a ratio of around 8:1 today, following the trend for a few days. Some of the sells seem very manufactured and shadow decent buys but I know several of us are amused by this play and continue to accumulate at these levels. Thank you for depressing the sp and allowing us to stock up.